Recent advances with recombinant bacterial vaccine vectors

Area of Science:

• Vaccinology
• Microbiology
• Immunology

Background:

• Bacterial vaccine vectors, including Bacille Calmette-Guerin (BCG), Listeria monocytogenes, Salmonellae, and Shigellae, have demonstrated potential in preclinical studies.
• Previous clinical trials in humans and non-human primates faced challenges, leading to a temporary decline in the development of this strategy.
• Recent advancements in bacterial DNA-vaccine vectors have reignited interest in utilizing bacteria as delivery systems for vaccines.

Purpose of the Study:

• To review the advantages and disadvantages of employing bacterial vaccine vectors.
• To explore the future potential and applications of these bacterial delivery systems in vaccinology.

Main Methods:

• This is a review article, synthesizing existing research on bacterial vaccine vectors.
• Literature search and analysis of studies involving various bacterial species as vaccine carriers.
• Evaluation of data from experimental animal models and past human clinical trials.

Main Results:

• Bacterial vectors have shown efficacy in animal models for delivering antigens.
• Challenges in human trials highlighted safety and immunogenicity concerns.
• Emerging DNA-vaccine vector technologies offer renewed promise and potential solutions.

Conclusions:

• Bacterial vaccine vectors offer a versatile platform for vaccine development, despite historical hurdles.
• Further research into novel bacterial DNA-vaccine vectors is crucial for overcoming past limitations.
• This approach holds significant future prospects for diverse vaccine applications.